Результати пошуку - Elizabeth Gaughan

  • Показ 1 - 6 результатів із 6
Уточнити результати
  1. 1
    Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

    Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature за авторством Joshua E. Reuss, Paul R. Kunk, Anne M. Stowman, Alejandro A. Gru, Craig L. Slingluff, Elizabeth Gaughan

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

    A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients за авторством Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese‐Bullock, Nolan A. Wages, William W. Grosh, Nikole Varhegyi, Mark E. Smolkin, Kelly T. Smith, Nadejda V. Galeassi, Donna H. Deacon, Elizabeth Gaughan, Craig L. Slingluff

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

    Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma за авторством Sapna P. Patel, Gina R. Petroni, Jason Roszik, Walter C. Olson, Nolan A. Wages, Kimberly A. Chianese‐Bullock, Mark E. Smolkin, Nikole Varhegyi, Elizabeth Gaughan, Kelly T. Smith, Kathleen Haden, Emily H. Hall, Sacha Gnjatic, Patrick Hwu, Craig L. Slingluff

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma

    MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma за авторством Víctor H. Engelhard, Rebecca C. Obeng, Kara L. Cummings, Gina R. Petroni, Angela L. Ambakhutwala, Kimberly A. Chianese‐Bullock, Kelly T. Smith, Amanda M. Lulu, Nikole Varhegyi, Mark E. Smolkin, Paisley T. Myers, Keira E. Mahoney, Jeffrey Shabanowitz, Nico Buettner, Emily H. Hall, Kathleen Haden, Mark Cobbold, Donald F. Hunt, Geoffrey R. Weiss, Elizabeth Gaughan, Craig L. Slingluff

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma

    Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma за авторством Douglas B. Johnson, Jennifer Bordeaux, Ju Young Kim, Christine Vaupel, David L. Rimm, Thai H. Ho, Richard W. Joseph, Adil Daud, Robert M. Conry, Elizabeth Gaughan, Leonel F. Hernandez‐Aya, Anastasios Dimou, Pauline Funchain, James W. Smithy, John S. Witte, Svetlana B. McKee, Jennifer S. Ko, John M. Wrangle, Bashar Dabbas, Shabnam Tangri, Jelveh Lameh, Jeffrey M. Hall, Joseph Markowitz, Justin M. Balko, Naveen Dakappagari

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry

    Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry за авторством Joseph Nowatzke, Paul Guedeney, Nicholas Palaskas, Lorenz Lehmann, Stéphane Éderhy, Han Zhu, Jennifer Cautela, Sanjeev Francis, Pierre‐Yves Courand, Anita Deswal, Steven M. Ewer, Mandar A. Aras, Dimitri Arangalage, Kambiz Ghafourian, Charlotte Fenioux, Daniel Finke, Giovanni Peretto, Vlad G. Zaha, Osnat Itzhaki Ben Zadok, Kazuko Tajiri, Nausheen Akhter, Joshua Levenson, Lauren A. Baldassarre, John R. Power, Shi Huang, Jean‐Philippe Collet, Javid J. Moslehi, Joe‐Elie Salem, Nazanin Aghel, Joachim Alexandre, Kazutaka Aonuma, Aarti Asnani, Juliane Behling, Mehmet Asım Bilen, Wendy Bottinor, Eve Cariou, Johnny Chahine, Wei-Ting Chan, Aman Chauhan, Max M. Cohen, Shanthini M. Crusz, Suran L. Fernando, Roberta Florido, Mauro Frigeri, Satoshi Fukushima, Elizabeth Gaughan, Benjamin P. Geisler, Lauren Gilstrap, Christian Grohé, Avirup Guha, Manhal Habib, Eva Simona Haegler-Laube, Andrew Haydon, Salim S. Hayek, Andrew Hughes, Rysk Imai, Yumi Katsume, Hideki Kimura, Lily Koo Lin, Carrie Lenneman, Daryl Leong, Vicky Makker, Nicolás Martínez‐Calle, Melissa Moey, Masahiro Mohri, Ryota Morimoto, Yoshinobu Moritoki, Anna Narezkina, Martin Nicol, Ajay K. Nooka, Olusola Ayodeji Orimoloye, Milan Patel, Michal Laufer Perl, Nicolas Piriou, J. Raikhelkar, Yasmin Raza, A. R. Rao, Sunil Reddy, Nobuhiko Seki, Karl Stangl, Andrew F. Stewart, Bryan Stringer, Balaji Tamarappoo, Yuichi Tamura, Franck Thuny, Sean Tierney, Romain Trésorier, Waqas Ullah, Jean-Jacques Von Hunolstein, Ellen Warner, Allison Weppler

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: